BeeWell

Trials & centers

Ask your doctor

Pick a condition

Recruiting trials

Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy

Phase 1 Recruiting

  • Mays Cancer Center, UT Health San Antonio, San Antonio, Texas, United States
Official record

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

Phase 3 Recruiting

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States
  • Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut, United States
  • Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut, United States
  • More sites
Official record

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Phase 2 Recruiting

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
  • More sites
Official record

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

Phase 2 Recruiting

  • Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States
Official record

Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ

Phase 3 Recruiting

  • Baylor College Of Medicine, Houston, Texas, United States
  • The University of Hong Kong-Shenzhen Hospital, Hong Kong, Hong Kong
  • Falun Lasarett, Falun, Dalarna County, Sweden
  • More sites
Official record

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Phase 3 Recruiting

  • Alaska Oncology and Hematology, Anchorage, Alaska, United States
  • Ironwood Cancer & Research Centers, Chandler, Arizona, United States
  • St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
  • More sites
Official record

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Phase 1 Recruiting

  • HonorHealth Research Institute, Scottsdale, Arizona, United States
  • START Los Angeles, Los Angeles, California, United States
  • Stanford Cancer Center, Palo Alto, California, United States
  • More sites
Official record

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

Observational Recruiting

  • Los Angeles General Medical Center, Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Official record
ClinicalTrials.gov

NCI-designated centers

Comprehensive & clinical

Alabama

Arizona

California

Colorado

Connecticut

District of Columbia

  • Georgetown Lombardi Comprehensive Cancer Center

    Washington, District of Columbia

Florida

Georgia

Hawai'i

Illinois

Indiana

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center

    Indianapolis, Indiana

Iowa

Kansas

Kentucky

Maryland

  • Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland

  • University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

    Baltimore, Maryland

Massachusetts

Michigan

Minnesota

Missouri

Nebraska

New Hampshire

New Jersey

New Mexico

  • University of New Mexico Cancer Research and Treatment Center

    Albuquerque, New Mexico

New York

North Carolina

Ohio

Oklahoma

Oregon

Pennsylvania

South Carolina

Tennessee

Texas

Utah

Virginia

Washington

  • Fred Hutchinson/University of Washington/Seattle Children's Cancer Consortium

    Seattle, Washington

Wisconsin

NCI-Designated Cancer Centers, June 10, 2026